Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 11, 2010 - Issue 2
Submit an article Journal homepage
214
Views
4
CrossRef citations to date
0
Altmetric
Clinical Trial Evaluation

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial

Evaluation of ‘Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, Phase III study (NCT00102804)’ trial. Lancet 2009 Oct 24;374(9699):1432-40. [Epub 2009 Sept 18]

Cesare Gridelli ‘S.G. Moscati’ Hospital, Division of Medical Oncology, Contrada Amoretta - 83100, Avellino (Italy) +39 0825 203574; +39 0825 203556; [email protected]
&
Massimo Di Maio National Cancer Institute – ‘G. Pascale’ Foundation, Clinical Trials Unit, Via Mariano Semmola, 80131 Napoli (Italy)
Pages 321-324 | Published online: 06 Jan 2010

Bibliography

  • Ciuleanu T, Brodowicz T, Zielinski C, Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, Phase III study. Lancet 2009: published online 20 September 2009, doi: 10.1016/S0140-6736(09)61497-5
  • Hanna N, Shepherd FA, Fossella FV, Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-97
  • Scagliotti GV, Parikh P, von Pawel J, Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-51
  • Scagliotti G, Hanna N, Fossella F, The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. Oncologist 2009;14:253-63
  • Pfister DG, Johnson DH, Azzoli CG, American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 2004;22:330-53
  • National Comprehensive Cancer Network – Clinical Practice Guidelines in Oncology. Non-small-cell lung cancer. Version 2.2009. Available from: www.nccn.org [Last accessed 5 November 2009]
  • Socinski MA, Crowell R, Hensing TE, American College of Chest Physicians. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines. 2nd edition. Chest 2007;132(3 Suppl):277S-89S
  • Fidias PM, Dakhil SR, Lyss AP, Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 2009;27:591-8
  • Socinski MA. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure? J Clin Oncol 2009;27:3268-70
  • Stinchcombe TE, West HL. Maintenance therapy in non-small-cell lung cancer. Lancet 2009: published online 20 September 2009, doi: 10.1016/S0140-6736(09)61598-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.